Filing Flows

Filing Flows › TransMedics Group (TMDX) › Guidance history

TransMedics Group (TMDX) guidance history: what it guided and what it reported

TransMedics Group gave guidance in 4 earnings releases on file since May 5, 2026. Its releases raised guidance twice and lowered it 0 times.

Revenue

Every guided period is still to be reported.

PeriodGuided (and how it moved)ReportedResultvs midpoint
FY2026$727M–$757M (May 5, 2026) → raised $737M–$757M (Aug 4, 2026) → raised $764M–$774M (Nov 5, 2026)—to be reported—

Tax rate

Every guided period is still to be reported.

PeriodGuided (and how it moved)ReportedResultvs midpoint
FY202625.0%–27.0% (Nov 5, 2026)—to be reported—

The latest quarter

TransMedics Group, Q3 2026: revenue $203M (+41% year over year), operating margin 13.9%, net earnings $17.1M, operating cash flow $36.0M. The chart follows the revenue to costs, profit and cash.

Questions

Does TransMedics Group beat its guidance?

TransMedics Group gave guidance in 4 earnings releases on file since May 5, 2026. Its releases raised guidance twice and lowered it 0 times.

How often does TransMedics Group raise guidance?

Its earnings releases raised guidance twice and lowered it 0 times since May 5, 2026.

Latest guidance and outlook →

Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.